A study led by researchers from the ibs.GRANADA will increase the ability to detect preterm birth
The project financed with a total of 500.00 euros, through FIBAO, by the Mind the Gap Program of the Botín Foundation, has allowed the creation of the technology-based company Innitus to develop "Fine Birt", a new technology based on the use of Torsion ultrasound for early and effective diagnosis of pathologies associated with the moment of childbirth: premature birth and labor induction.
The innovation and development project, led by the research group TEC-12 BIOMECÁNICA, of the Area of Advanced Therapies and New Biomedical Technologies of ibs.GRANADA, led by Dr. Francisca Molina, FEA of Obstetrics and Gynecology at the Hospital Clínico San Cecilio de Granada, have developed this new device, dubbed Fine Birth, which is committed to replacing current diagnostic techniques that barely have 30% reliability for specialists.
Preterm birth continues to be one of the main health threats of the XNUMXst century. The WHO has included among its millennium goals the reduction of health problems and the lives lost as a result of premature births.
Of the different scenarios of prematurity, the "Threatened Premature Birth" is the most frequent (50% of cases), and the most uncertain for women. When a pregnant woman goes to the emergency room with symptoms of spontaneous labor, the gynecologist must determine if she is really in labor (and should be admitted) or if it is a false threat.
In most cases, this decision is made based on the result of cervicometry, a technology that involves a high degree of discretion on the part of the gynecologist, and there is a high rate of (unnecessary) hospital admissions in favor of the safety of the the patient.
Fine Birth is the cheapest (70 times lower cost than in-vitro diagnostics) and reliable alternative to cervicometry, and the only one that allows a diagnosis to be made in real time.
Technology fine birth, developed by the Granada startup INNITIUS, will be integrated into the ultrasound machines available in gynecological consultations, and, by analyzing the consistency of the woman's cervix, it will be able to diagnose in real time whether the patient is in labor or is a false threat.
Other techniques, such as the Fibronectin tests (FFN Test), are not recommended by current health protocols and the results of the same can take weeks.
INNITIUS, a startup owned by the Botín Foundation's Mind the Gap investment vehicle, has just opened a new round of financing for € 1.800.000.
INNITIUS, already owned by the investment vehicle Mind the Gap of the Botín Foundation), has just opened a new round of financing amounting to €1.800.000 to validate the reliability of this technology with more than 450 pregnant women in hospitals in Granada, London and Lodz. A section of this investment has been opened to small investors, who will be able to participate through Capital Cell's “equity crowdfunding” platform for Health projects.
About INNITIUS
INNITIUS is a spinoff of the University of Granada and the Andalusian Health Service founded in 2017 by a team of researchers led by Guillermo Rus and Francisca Molina. The company develops medical devices for the diagnosis of human pathologies that manifest themselves through changes in the mechanical properties (consistency) of tissues, through the use of its own technology, torsion waves. Our innovative solutions have several points in common:
- They are based on the principle of torsion waves, a new technology created by the founders' research group.
- They are born from the collaboration between doctors and civil engineers.
- They solve problems that are currently inefficiently addressed by existing solutions.
- They are an attractive licensing opportunity for big brands in the ultrasound market.